Cargando...
Effectiveness and safety of the conversion to MeltDose(®) extended‐release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study
Tacrolimus is the cornerstone of immunosuppressive therapy after kidney transplantation. Its narrow therapeutic window mandates serum level strict monitoring and dose adjustments to ensure the optimal risk‐benefit balance. This observational retrospective study analyzed the effectiveness and safety...
Guardado en:
| Publicado en: | Clin Transplant |
|---|---|
| Autores principales: | , , , , , , , , , , , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7050537/ https://ncbi.nlm.nih.gov/pubmed/31815310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ctr.13767 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|